WhiteLab Genomics

whitelabgx.com →

+113%

est. 2Y upside i

HealthcareAI & MLSeries A

Unleashing the potential of DNA and RNA based therapies using AI

Rank

#305

Sector

Biotechnology, Artificial Intelligence, Genomic Medicine

Est. Liquidity

~4Y

Data Quality

Data: Medium

WhiteLab Genomics offers a high-upside equity opportunity due to its 94.7% YoY growth and strong partnerships, but the risk is higher given a stale $74M estimated valuation from a 2022 round and likely near-term dilution.

Last updated: July 19, 2026

Bull (30%)+195%

IPO window or category leadership pushes multiple to 12x; projected revenue $19.4M yields $232.8M exit, net of 20% dilution gives 195% upside.

Base (45%)+116%

Multiple converges to public comp median of 9x; exit at $174.6M, net dilution yields 116% upside.

Bear (25%)+11%

Multiple compresses to 5x due to market conditions or competitive pressure; exit at $97M, net dilution yields 11% upside. Preference stack not triggered.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Funding Intensity

14%

Total funding $10M, estimated valuation $74M, resulting in a 13.5% preference stack; common is vulnerable if exit below $10M, unlikely in base case.

Dilution Risk

high

Given high cash burn and only $10M raised, a significant Series B round within 18 months is expected, potentially diluting existing shareholders by 20-25%.

Secondary Liquidity

none

No secondary market activity known; equity likely illiquid until exit.

Other — 1 role

  • Careers · Paris, Boston, Montréal
View all 1 open roles at WhiteLab Genomics →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on WhiteLab Genomics's data — designed to show you've done your homework.

  • 1

    “How do you plan to stay ahead of larger pharma and AI-driven competitors in genomic medicine?”

  • 2

    “What are the key drivers for customer acquisition and expansion beyond subscriptions?”

  • 3

    “Given the company's funding stage and valuation, what is the expected timeline for liquidity events and how does the equity package compare to market?”

Community

Valuation Sentiment

Our model estimates +113% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.